Your browser doesn't support javascript.
Practice of non-pharmaceutical interventions against COVID-19 and reduction of the risk of influenza-like illness: a cross-sectional population-based study.
Youssef, Dalal; Issa, Ola; Kanso, Maysaloun; Youssef, Janet; Abou-Abbas, Linda; Abboud, Edmond.
  • Youssef D; Research Center Bordeaux Population Health, Institut de Santé Publique, d'épidémiologie et de Développement (ISPED), Bordeaux University, Bordeaux, France. dyoussef@moph.gov.lb.
  • Issa O; Clinical Trial Program, Ministry of Public Health, Beirut, Lebanon. dyoussef@moph.gov.lb.
  • Kanso M; Preventive Medicine Department, Ministry of Public Health, Beirut, Lebanon. dyoussef@moph.gov.lb.
  • Youssef J; Ministry of Public Health, Beirut, Lebanon.
  • Abou-Abbas L; Ministry of Public Health, Beirut, Lebanon.
  • Abboud E; Al Zahraa Hospital University Medical Center, Beirut, Lebanon.
J Pharm Policy Pract ; 15(1): 54, 2022 Aug 30.
Article in English | MEDLINE | ID: covidwho-2021345
ABSTRACT

INTRODUCTION:

While the widespread implementation of the non-pharmaceutical interventions was intended to contain the COVID-19 pandemic, such measures could be also effective in limiting the spread of other respiratory infections. This study aimed to examine the association between the implementation of personal protective measures and the occurrence of influenza-like illnesses (ILI) in the general population.

METHODS:

An online retrospective cross-sectional observational study was conducted in April 2021 to assess cases of ILI among Lebanese adults aged 18 years and above, from all Lebanese governorates during the 2020-2021 flu season. Data were collected using a convenience sampling method. In addition to their socio-demographic information, participants were asked about their frequency of implementing personal protective measures and if they have experienced symptoms of ILI in the previous 6 months. The overall score of the personal protective measures was computed. Multivariable logistic regression was performed to examine the association between participants' level of adoption of personal protective measures against COVID-19 and the occurrence of ILI.

RESULTS:

Among the 1019 Lebanese adults participating in this study, 352 (34.54%) of them reported symptoms of ILI between October 2020 and March 2021. Lebanese adults who wore their facemasks frequently or always were less likely to suffer from symptoms of ILI than others who did not wear the mask (aOR = 0.452, 95% CI = 0.349-0.693, p < 0.001). Similarly, adults who adopt the following protective measures washing hands (aOR = 0.608, 95% CI = 0.524-0.922, p < 0.001), respecting cough etiquette (aOR = 0.763, 95% CI = 0.598-0.918, p < 0.001), disinfecting surface (aOR = 0.892, 95% CI = 0.632-0.911, p = 0.012), avoiding crowded places (aOR = 0.739, 95% CI = 0.688-0.903, p = 0.049), respecting physical distancing (aOR = 0.646, 95% CI = 0.482-0.833, p = 0.031) on a regular basis (frequently/always) were less likely to report symptoms of influenza-like illnesses when compared with those who did not adhere at all to these measures.

CONCLUSION:

Our study highlighted the potential of personal protective measures against COVID-19 in reducing the transmission of respiratory infections such as ILI. Such findings might be invested during influenza season, particularly among groups at high risk of developing severe complications. Exploring trends detected by the national severe acute respiratory infection surveillance system is recommended to confirm the utility of these measures.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: J Pharm Policy Pract Year: 2022 Document Type: Article Affiliation country: S40545-022-00450-y

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: J Pharm Policy Pract Year: 2022 Document Type: Article Affiliation country: S40545-022-00450-y